On the basis of these results, we hypothesized that in CRC, TGFBI levels are maintained through TGFβ signaling in stromal cells, whereas in CRC-LM, TGFBI is also directly secreted by cancer cells that can respond to TGFβ stimulation. Here, TGFBI is linked to cancer.